Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
56,178,304
-
Share change
-
-822,484
-
Total reported value
-
$8,948,272,058
-
Put/Call ratio
-
252%
-
Price per share
-
$159.31
-
Number of holders
-
475
-
Value change
-
-$100,056,709
-
Number of buys
-
238
-
Number of sells
-
179
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2022
As of 31 Dec 2022,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
475 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,178,304 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, STATE STREET CORP, LSV ASSET MANAGEMENT, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, FRANKLIN RESOURCES INC, and Polaris Capital Management, LLC.
This page lists
475
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.